Table 1.
Baseline Cohort Characteristics of Included Studies
| Study | Bunch et al. (2013)18 |
De Greef et al. (2018)8 |
Hussein et al. (2016)9 |
Kawaji et al. (2019)19 |
Lunati et al. (2018)20 |
Bisbal et al. (2019)17 |
|---|---|---|---|---|---|---|
| Sample, N | 684 | 1000 | 1241 | 1206 | 510 | 309 |
| Mean Age, years | 65 | 60 | 61 | 64 | 59 | 57 |
| Female, % | 39 | 28 | 22 | 29 | 33 | 29 |
| BMI, kg/m2 | nr | 28 | nr | nr | 27 | 28 |
| Paroxysmal AF, % | 58 | 59 | 0 | 71 | nr | 67 |
| Prior Stroke, % | 6 | 7 | nr | 10 | 5 | 3 |
| Diabetes mellitus, % | 23 | 9 | 9 | 16 | 5 | 8 |
| Hypertension, % | 75 | 42 | 39 | 59 | 47 | 45 |
| Heart Failure, % | 30 | 42 | nr | 9 | nr | Nr |
| LA diameter, mm | nr | nr | nr | 41 | 41 | 42 |
| LVEF, % | 53 | nr | 52 | 63 | 60 | 61 |
| CHADS2 Score | 1.6 | nr | nr | 1.2 | nr | nr |
| CHADS2 VASc | nr | 1 | nr | 2.0 | nr | 1 |
| Prior Ineffective AAD, no. | nr | 2.1 | nr | nr | 1.7 | nr |
| Blanking Period | 3 months | 1 month | 3 months | 1.5 months | 1.5 months | None |
| Mean Follow Up | 39 months | 43 months | 24 months | 60 months | 16 months | 14 months |
Abbreviations: BMI, body mass index; LA, left atrial; LVEF, left ventricular ejection fraction; nr, not reported